• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Christopher S. Lathan, MD, MS, MPH


  • Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL.Racial disparities in an aging population: The relationship between age and race in the management of African American men with high-risk prostate cancer.Journal Of Geriatric Oncology. 2014 May 23.
  • Waldman LT, Bean W, Levine AL, Cohen-Bearak A, Phelps FA, Svoboda L, Freedman R, Elfiky A, Berlin S, Abel GA, Deutsch C, Lathan CS.Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery.Healthcare (Amst). 2013 Dec;1(3-4):130-135.
  • Traeger L, Cannon S, Keating NL, Pirl WF, Lathan C, Martin MY, He Y, Park ER.Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer.J Clin Oncol. 2014 Jan 10;32(2):107-13.
  • Yasuda H, Park E, Yun CH, Sng NJ, Lucena-Araujo AR, Yeo WL, Huberman MS, Cohen DW, Nakayama S, Ishioka K, Yamaguchi N, Hanna M, Oxnard GR, Lathan CS, Moran T, Sequist LV, Chaft JE, Riely GJ, Arcila ME, Soo RA, Meyerson M, Eck MJ, Kobayashi SS, Costa DB.Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.Sci Transl Med. 2013 Dec 18;5(216):216ra177.
  • Lathan C, Frank DA.ACP Journal Club. Review: low-dose CT screening reduces lung cancer and mortality in current or former smokers.Ann Intern Med. 2013 Nov 19;159(10):JC3.
  • Gray SW, Hicks-Courant K, Lathan CS, Garraway L, Park ER, Weeks JC.Attitudes of patients with cancer about personalized medicine and somatic genetic testing.J Oncol Pract. 2012 Nov;8(6):329-35, 2 p following 335.
  • Lynch JA, Khoury MJ, Borzecki A, Cromwell J, Hayman LL, Ponte PR, Miller GA, Lathan CS.Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational research.Genet Med. 2013 Feb 28.
  • Jimenez R, Zhang B, Joffe S, Nilsson M, Rivera L, Mutchler J, Lathan C, Paulk ME, Prigerson HG.Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?.J Palliat Med. 2013 Mar;16(3):256-62.
  • Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA.Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma.Clin Cancer Res. 2012 Oct 15;18(20):5773-5779.
  • Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM.Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.Am J Surg Pathol. 2012 Aug;36(8):1222-7.
  • Lathan CS, Okechukwu C, Drake BF, Bennett GG.Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey.Cancer. 2010 Apr 15;116(8):1981-6.
  • Schapira L,Gordon-Rowe L,Martignetti R,Washington D,Bartholomay M,Greenberg D,Lathan C,LaFrancesca J,Lynch T,Chabner B.Racism in the chemotherapy infusion unit: a nurse's story.Oncologist. 2008 Nov;13(11):1177-80.
  • Lathan CS,Neville BA,Earle CC.Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer.J Clin Oncol. 2008 Sep 10;26(26):4347-52.
  • Drake BF,Lathan CS,Okechukwu CA,Bennett GG.Racial differences in prostate cancer screening by family history.Ann Epidemiol. 2008 Jul;18(7):579-83.
  • Balboni TA, Vanderwerker LC, Block SD, Paulk ME, Lathan CS, Peteet JR, Prigerson HG.Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life.J Clin Oncol. 2007 Feb 10;25(5):555-60.
  • Lathan CS, Neville BA, Earle CC.The effect of race on invasive staging and surgery in non-small-cell lung cancer.J Clin Oncol. 2006 Jan 20;24(3):413-8.